1Stratton I M, Adler A I, Neil H A, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes ( UK- PDS 35 ) : prospective observational study [J]. BMJ, 2000, 321 (7258) :405 -412.
2Boebm B, Home P D, Behread C, et al. Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients[ J ]. Diabet Med, 2002,19 (5): 393 - 399.
4Wolever TMS, Chiassen JL, Csima A, et al. Variation of postprandial plasma glucose, palatability, and symptoms associated with a standardized mixed test meal versus 75 g glucose. Diabetes Care,1998,21:336-340.
5Coutinho M, Gerstein HC, Wang Y, et al. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care, 1999,22:233-240.
6DECODE Study Group, the European Diabetes Epidemiology Group.Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med, 2001 ; 12 ; 161 : 397-405.
7Nakagami T; DECODA Study Group. Hypergiycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia, 2004,47:385-394.
8Sorkin JD, Muller DC, Fleg JL, et al.The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality, Data from the Baltimore longitudinal study of aging with a critical review of the literature. Diabetes Care, 2005,28:2626-2632.
9Hanefeld M, Koehler C, Henkel E, et al. Post-challenge hyperlycaemia relates more strongly than fasting hyperglycaemia with carotid intima-media thickness: the RIAD Study. Risk Factors in Impaired Glucose Tolerance for atherosclerosis and Diabetes. Diabet Med, 2000,17: 835-840.
10Hanefeld M, Chiasson JL, Koehler C, et al. Acarbose slows pregression of intima-media thickness of the carotid artiefies in subjects with impaired glucose tolerance. Stroke, 2004,35:1073-1078.
4Christiansen JS, Vaz JA, Metelko Z, et al. Twice daily biphasic insulin aspart improves post prandial glycemic control more effectively than twice daily NPH insulin, with low risk of hypoglycemia, in patients with type 2 diabetes [ J ]. Diabetes Obes Metab, 2003,5(6) : 446.
6The ACE/ADA Task Force on Inpatient Diabetes. American college of endocrinology and american Diabetes association consensus statement on inpatient diabetes and glycemic control[J]. Diabetes Care, 2006,29(8) : 1 955.
7陆祖谦.预混胰岛素类似物有助于HbA1C控制达标[N].中国医学论坛报,2007:33(10).
8Nathan D M.Clinical practice:initial management of glycemia in type 2 diabetes mellitus[J].N Engl J Med,2002,347:1342-1349.
10Garber A J,Wahlen J,Wahl T,et al.Attainment of glycaemic goals in type 2 diabetes with once-,twice-,or thrice-daily dosing with biphasic insulin aspart 70/30(The 1-2-3 study)[J].Diabetes,Obesity and Metabolism,2006,8:58-66.
